InsiderClue
Insiders · Profile

MOORE ALISON

President and CEO at CODEXIS · Chief Technical Officer at Allogene Therapeutics. Filing since 3 Jun 2019. CIK 0001754937

CDXS CODEXIS, INC. President and CEO · 2 trades ALLO Allogene Therapeutics, Inc. Chief Technical Officer · 15 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CDXS CODEXIS, INC.
6 Feb 2026
President and CEO
Sold at will
3,826
$5.00K
1.5%
CDXS CODEXIS, INC.
13 Oct 2025
Chief Technical Officer
Sold at will
6,239
$15.63K
3.6%
ALLO Allogene Therapeutics, Inc.
15 Mar 2022
Chief Technical Officer
Sold, plan not stated
8,698
$66.39K
6.7%
ALLO Allogene Therapeutics, Inc.
15 Mar 2021
Chief Technical Officer
Sold, plan not stated
6,164
$235.09K
5.7%
ALLO Allogene Therapeutics, Inc.
13 Oct 2020
Chief Technical Officer
Sold, plan not stated
11,031
$463.30K
9.2%
ALLO Allogene Therapeutics, Inc.
12 Oct 2020
Chief Technical Officer
Sold, plan not stated
24,233
$1.02M
18.3%
ALLO Allogene Therapeutics, Inc.
9 Oct 2020
Chief Technical Officer
Sold, plan not stated
39,509
$1.62M
26.7%
ALLO Allogene Therapeutics, Inc.
8 Oct 2020
Chief Technical Officer
Sold, plan not stated
5,065
$207.67K
4.1%
ALLO Allogene Therapeutics, Inc.
6 Oct 2020
Chief Technical Officer
Sold, plan not stated
44,574
$1.78M
27.5%
ALLO Allogene Therapeutics, Inc.
16 Mar 2020
Chief Technical Officer
Sold, plan not stated
3,750
$71.98K
5.6%
ALLO Allogene Therapeutics, Inc.
18 Sep 2019
Chief Technical Officer
Sold, plan not stated
21,067
$676.87K
24.2%
ALLO Allogene Therapeutics, Inc.
17 Sep 2019
Chief Technical Officer
Sold, plan not stated
22,503
$722.56K
25.4%
ALLO Allogene Therapeutics, Inc.
16 Sep 2019
Chief Technical Officer
Sold, plan not stated
5,257
$168.23K
7.4%
ALLO Allogene Therapeutics, Inc.
30 Jul 2019
Chief Technical Officer
Sold, plan not stated
11,819
$352.74K
15.3%
ALLO Allogene Therapeutics, Inc.
29 Jul 2019
Chief Technical Officer
Sold, plan not stated
23,815
$699.87K
26.7%
ALLO Allogene Therapeutics, Inc.
26 Jul 2019
Chief Technical Officer
Sold, plan not stated
13,193
$384.99K
16.8%
ALLO Allogene Therapeutics, Inc.
3 Jun 2019
Chief Technical Officer
Sold, plan not stated
48,828
$1.31M
56.5%
17 decisions on file.